| Cell line name |
MSR3-mel |
|---|
| Synonyms |
AUMA |
|---|
| Accession |
CVCL_VV18 |
|---|
| Resource Identification Initiative |
To cite this cell line use: MSR3-mel (RRID:CVCL_VV18) |
|---|
| Comments |
Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014. |
|---|
| HLA typing |
Source: PubMed=11668505
| Class I | | HLA-A | A*01:01,11:01 | | HLA-B | B*37:01,52:01:01:01 | | HLA-C | C*06:02,12:02 |
|
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Children:
|
|---|
| Originate from same individual |
CVCL_VV17 ! MSR3-EBV |
|---|
| Sex of cell |
Sex unspecified |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=10363990
Silvia Tanzarella, Vincenzo Russo, Ilaria Lionello, Piero Dalerba, Donata Rigatti, Claudio Bordignon, Catia Traversari;
Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.
Cancer Res. 59:2668-2674(1999) PubMed=11668505; DOI=10.1002/ijc.1452
Alfonso Serrano, Silvia Tanzarella, Ilaria Lionello, Rosa Mendez, Catia Traversari, Francisco Ruiz-Cabello Osuna, Federico Garrido;
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.
Int. J. Cancer 94:243-251(2001) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q95991314
|
|---|
| Entry history |
|---|
| Entry creation | 24-May-2019 |
|---|
| Last entry update | 14-Aug-2025 |
|---|
| Version number | 5 |
|---|
